James F. Emigh, VP Corporate Development at ACURA PHARMACEUTICALS, INC (ACUR), bought 15,000 shares at $1.21 ($18K) on 2014-05-16, disclosed to the SEC on 2014-05-19.
Open-market purchase of $18k ACUR by VP Corporate Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |